Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children

I Slapak, J Skoupa, P Strnad, P Hornik

. 2008 ; 134 (1) : 67-74.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu multicentrická studie, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026708

OBJECTIVE: To evaluate the potential of nasal isotonic saline application to prevent reappearance of cold and flu in children during the winter. DESIGN: Prospective, multicenter, parallel-group, open, and randomized comparison. SETTING: Eight pediatric outpatient clinics. PATIENTS: A total of 401 children (aged 6-10 years) with uncomplicated cold or flu. INTERVENTIONS: We randomly assigned patients to 2 treatment groups, one with just standard medication, the other with nasal wash with a modified seawater solution (Physiomer) plus standard medication, and observed them for 12 weeks. MAIN OUTCOME MEASURES: The primary efficacy end points were nasal symptoms resolution during acute illness (visits 1 and 2). We also looked for reappearance of cold or flu, consumption of medication, complications, days off school, and reported days of illness during the following weeks when preventive potential was evaluated (visits 3 and 4). RESULTS: At visit 2, patients in the saline group achieved primary end points (measured on a 4-point numeric scale on which 1 indicated no symptoms and 4, severe symptoms) in the parameters nasal secretion and obstruction (mean scores vs nonsaline group, 1.79 vs 2.10 and 1.25 vs 1.58, respectively) (P < .05 for both). During the prevention phase (at visit 3, 8 weeks after study entry) patients in the saline group showed significantly lower scores in sore throat, cough, nasal obstruction, and secretion (P < .05 for all). By visit 3, significantly fewer children in the saline group were using antipyretics (9% vs 33%), nasal decongestants (5% vs 47%), mucolytics (10% vs 37%), and systemic antiinfectives (6% vs 21%) (P < .05 for all). During the same period children in the saline group also reported significantly fewer illness days (31% vs 75%), school absences (17% vs 35%), and complications (8% vs 32%) (P < .05 for all). Similar results were found at the final visit. CONCLUSION: Children in the saline group showed faster resolution of some nasal symptoms during acute illness and less frequent reappearance of rhinitis subsequently.

Citace poskytuje Crossref.org

000      
00000naa 2200000 a 4500
001      
bmc10026708
003      
CZ-PrNML
005      
20111210192434.0
008      
101029s2008 xxu e eng||
009      
AR
024    __
$a 10.1001/archoto.2007.19 $2 doi
035    __
$a (PubMed)18209140
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Šlapák, Ivo, $d 1952- $7 jn20000402849
245    10
$a Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children / $c I Slapak, J Skoupa, P Strnad, P Hornik
314    __
$a Pediatric Otorhinolaryngology Clinic, Teaching Hospital Brno, Czech Republic.
520    9_
$a OBJECTIVE: To evaluate the potential of nasal isotonic saline application to prevent reappearance of cold and flu in children during the winter. DESIGN: Prospective, multicenter, parallel-group, open, and randomized comparison. SETTING: Eight pediatric outpatient clinics. PATIENTS: A total of 401 children (aged 6-10 years) with uncomplicated cold or flu. INTERVENTIONS: We randomly assigned patients to 2 treatment groups, one with just standard medication, the other with nasal wash with a modified seawater solution (Physiomer) plus standard medication, and observed them for 12 weeks. MAIN OUTCOME MEASURES: The primary efficacy end points were nasal symptoms resolution during acute illness (visits 1 and 2). We also looked for reappearance of cold or flu, consumption of medication, complications, days off school, and reported days of illness during the following weeks when preventive potential was evaluated (visits 3 and 4). RESULTS: At visit 2, patients in the saline group achieved primary end points (measured on a 4-point numeric scale on which 1 indicated no symptoms and 4, severe symptoms) in the parameters nasal secretion and obstruction (mean scores vs nonsaline group, 1.79 vs 2.10 and 1.25 vs 1.58, respectively) (P < .05 for both). During the prevention phase (at visit 3, 8 weeks after study entry) patients in the saline group showed significantly lower scores in sore throat, cough, nasal obstruction, and secretion (P < .05 for all). By visit 3, significantly fewer children in the saline group were using antipyretics (9% vs 33%), nasal decongestants (5% vs 47%), mucolytics (10% vs 37%), and systemic antiinfectives (6% vs 21%) (P < .05 for all). During the same period children in the saline group also reported significantly fewer illness days (31% vs 75%), school absences (17% vs 35%), and complications (8% vs 32%) (P < .05 for all). Similar results were found at the final visit. CONCLUSION: Children in the saline group showed faster resolution of some nasal symptoms during acute illness and less frequent reappearance of rhinitis subsequently.
650    _2
$a aplikace intranazální $7 D000281
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a rozdělení chí kvadrát $7 D016009
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a isotonické roztoky $x aplikace a dávkování $7 D007552
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rýma $x farmakoterapie $x prevence a kontrola $7 D012220
650    _2
$a chlorid sodný $x aplikace a dávkování $7 D012965
650    _2
$a neparametrická statistika $7 D018709
650    _2
$a výsledek terapie $7 D016896
650    _2
$a financování organizované $7 D005381
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Skoupá, Jana $7 xx0104307
700    1_
$a Strnad, Petr, $d 1963- $7 xx0095404
700    1_
$a Horník, Pavel $7 xx0076620
773    0_
$w MED00000557 $t Archives of otolaryngology - head & neck surgery $g Roč. 134, č. 1 (2008), s. 67-74 $x 0886-4470
910    __
$a ABA008 $b x $y 7
990    __
$a 20101029064841 $b ABA008
991    __
$a 20101029152935 $b ABA008
999    __
$a ok $b bmc $g 801815 $s 666571
BAS    __
$a 3
BMC    __
$a 2008 $b 134 $c 1 $d 67-74 $i 0886-4470 $m Archives of otolaryngology - head & neck surgery $n Arch Otolaryngol Head Neck Surg $x MED00000557
LZP    __
$a 2010-B3/vtme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...